NOTICE: February Drug Manufacturer Call on Implementation of the IRA Medicare Provisions     

Relevant to:    All Drug Manufacturers 

 The purpose of this memorandum is to notify drug manufacturers that the Centers for Medicare & Medicaid Services (CMS), Center for Medicare hosts monthly calls on implementation of the Medicare provisions of the Inflation Reduction Act of 2022 (Public Law 117-169). 

See the full guidance for more information.